BXP vs CDTX · rev $3.48B vs rev $1.3M
Boston Properties Inc (BXP) versus Cidara Therapeutics Inc (CDTX) — a side-by-side from cached financials, not a winner call.
Boston Properties Inc (BXP) is a reit - office company listed on US.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
Latest reported BXP revenue for 2025-12-31 was $3.48B. Net income was $276.8M. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BXP currently screens at market cap $12.12B.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
BXP currently screens at market cap $12.12B. CDTX currently screens at market cap $6.96B.
Not investment advice. Open the BXP and CDTX stock pages for the full models.
Not investment advice.